Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px

News > All

Total search results: 6381 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 62 63 64  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Roche. (2/25/19). "Press Release: Roche Enters into Definitive Merger Agreement to Acquire Spark Therapeutics". Basel. 2019-02-25
Danaher Corporation. (2/25/19). "Press Release: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion". Washington, DC. 2019-02-25
Medigene AG. (2/25/19). "Press Release: European Patent Covering TCR Library Suitable for the Development of Neoantigen-specific TCRs". Martinsried. 2019-02-25
Lonza Group AG. (2/25/19). "Press Release: Lonza Strengthens Pharma, Biotech and Nutrition Offerings with Aligned Structure and New Executive Committee Appointment". Basel. 2019-02-25
Orchard Therapeutics Ltd.. (2/25/19). "Press Release: Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD". Boston, MA & London. 2019-02-25
CRISPR Therapeutics AG. (2/25/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results". Zug & Cambridge, MA. 2019-02-25
Boehringer Ingelheim. (2/25/19). "Press Release: New Chief Medical Officer Appointed". Ingelheim. 2019-02-25
Mobidiag Oy. (2/25/19). "Press Release: Mobidiag Signs Multiple International Agreements for Distribution of Its Amplidiag and Novodiag Diagnostic Solutions". 2019-02-25
Themis Bioscience GmbH. (2/25/19). "Press Release: Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate". Vienna. 2019-02-25
Orchard Therapeutics Ltd.. (2/22/19). "Press Release: Orchard Therapeutics Presents Two-year Follow-up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID". Boston, MA & London. 2019-02-22
Eppendorf AG. (2/21/19). "Press Release: Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG". Hamburg. 2019-02-21
Ynsect S.A.. (2/21/19). "Press Release: Ÿnsect Raises $125m to Become World Leader in Alternative Protein". Paris & London. 2019-02-21
HeiScreen GmbH. (2/21/19). "Press Release: Researchers at Heidelberg University Hospital Develop First Marketable Blood Test for Breast Cancer". Düsseldorf & Heidelberg. 2019-02-21
PX’Therapeutics S.A.. (2/20/19). "Press Release: 2019 – PX’Therapeutics Develops Its Services Offer". 2019-02-20
Evotec AG. (2/20/19). "Press Release: Evotec and Helmholtz Centre Joining Platforms and Forces for Novel Antibiotics". Hamburg & Braunschweig. 2019-02-20
Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam. 2019-02-20
BASF AG. (2/20/19). "Press Release: BASF’s Investment into Alchemist Accelerator Promotes Digital Innovations in the Chemical Industry". San Francisco, CA & Ludwigshafen. 2019-02-20
Aidence B.V.. (2/20/19). "Press Release: Aidence Raises €10 Million Series A to Revolutionise the Medical Imaging Industry". 2019-02-20
BiomX Ltd.. (2/20/19). "Press Release: BiomX Raises $32 Million in Series B Financing. Proceeds Will Be Used Primarily to Advance Leading IBD and Acne Programs to the Clinic". Ness Ziona. 2019-02-20
Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris. 2019-02-20
Cell Mogrify Ltd.. (2/20/19). "Press Release: Mogrify Raises $3.7 Million USD Seed Funding to Accelerate its Mission to Transform Cell Therapy via Direct Cellular Conversion". Cambridge. 2019-02-20
ADC Therapeutics S.A.. (2/20/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma" 2019-02-20
Bicycle Therapeutics Ltd.. (2/20/19). "Press Release: Bicycle Therapeutics Strengthens Executive Team with Key Changes. Peter Leone Appointed Chief Business Officer – Lee Kalowski, Chief Financial Officer, Promoted to U.S. President". Cambridge & Boston, 2019-02-20
Sartorius AG. (2/19/19). "Press Release: Sartorius Closes Fiscal 2018 Successfully and Aims to Further Expand". Göttingen. 2019-02-19
MDxHealth S.A.. (2/19/19). "Press Release: MDxHealth Appoints Michael K. McGarrity as CEO. Dr. Jan Groen Continues as an Advisor to the Board". Irvine, CA & Herstal. 2019-02-19
MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. 2019-02-19
GT Gain Therapeutics S.A.. (2/19/19). "Press Release: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indi 2019-02-19
Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Polatuzumab Vedotin in Previously Treated Aggressive Lymphoma". Basel. 2019-02-19
Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Personalised Medicine Entrectinib". Basel. 2019-02-19
CRISPR Therapeutics AG. (2/19/19). "Press Release: CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement". Zug, Cambridge, MA & Durham, NC. 2019-02-19
Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2019-02-19
Merck KGaA. (2/19/19). "Press Release: Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method". Darmstadt. 2019-02-19
France Biotech. (2/19/19). "Press Release: France Biotech Announces Launch of HealthTech Investor Day in Paris on June 25th, 2019". Paris. 2019-02-19
OBN (UK) Ltd.. (2/19/19). "Press Release: OBN Launches New Purchasing Platform to Provide E-Commerce Solution for its Members". 2019-02-19
S-Biomedic N.V.. (2/18/19). "Press Release: Microbiome Pioneer S-Biomedic Completes Series A Round with DSM Venturing". Belgium. 2019-02-18
Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. 2019-02-18
Sphere Fluidics Ltd.. (2/18/19). "Press Release: Oxford Genetics and Sphere Fluidics Announce a Multi-partner Collaboration to Expedite the Development of Automated Microfluidic Systems for Rapid and High-throughput Gene Editing in Mammalian Cell Lines". 2019-02-18
Merck KGaA. (2/16/19). "Press Release: Pivotal Phase III Data for Bavencio (avelumab) plus Inlyta (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine [Not intended for US, Canada and UK-based media]". Darmstadt & 2019-02-16
Sygnature Discovery Ltd.. (2/15/19). "Press Release: Sygnature Discovery Starts 2019 with Two Senior Appointments – Dr Allan Jordan and Ms Louisa Jordison". Nottingham. 2019-02-15
Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. 2019-02-15
UCB S.A.. (2/15/19). "Press Release: UCB Builds on Its R&D Footprint to Form a Research Satellite Facility within King’s College London". Brussels & Slough. 2019-02-15
Hookipa Pharma Inc.. (2/15/19). "Press Release: Hookipa Appoints Michael A. Kelly as Independent Director". New York, NY & Vienna. 2019-02-15
InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. 2019-02-14
High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". 2019-02-14
Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. 2019-02-14
BioMed X GmbH. (2/14/19). "Press Release: Merck and BioMed X Expand Collaboration to Immunology Research". Heidelberg. 2019-02-14
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
Codexis, Inc.. (2/14/19). "Press Release: Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria". Redwood City, CA. 2019-02-14
Vor Biopharma, Inc.. (2/14/19). "Press Release: Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia". Boston, MA. 2019-02-14
Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. 2019-02-13
Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. 2019-02-13
Lonza Group AG. (2/13/19). "Press Release: Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate". San Diego, CA & Basel. 2019-02-13
ADC Therapeutics S.A.. (2/13/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Imfinzi (durvalumab) in Multiple Types of Advanced Non-Hodgkin Lymphoma". Lausanne. 2019-02-13
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Boehringer Ingelheim (Canada) Ltd.. (2/12/19). "Press Release: Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials". Burlington, ON & Markham, ON. 2019-02-12
Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. 2019-02-12
Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel. 2019-02-12
Bruker Corporation. (2/11/19). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results". Billerica, MA. 2019-02-11
Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". 2019-02-11
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Follicum AB. (2/11/19). "Press Release: Follicum Selects Novel Peptide Drug Candidate for the Treatment of Diabetes and Protection of Beta Cells". 2019-02-11
Merck KGaA. (2/11/19). "Press Release: FDA Accepts sBLA and Grants Priority Review for Bavencio (avelumab) plus Inlyta (axitinib) for the Treatment of Advanced Renal Cell Carcinoma [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-02-11
Lonza Group AG. (2/11/19). "Press Release: Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability". Walkersville, MD & Basel. 2019-02-11
UCB S.A.. (2/11/19). "Press Release: UCB and Epilepsy Society Announce Pioneering UK Genomics R&D collaboration". Slough & Brussels. 2019-02-11
Eurofins. (2/11/19). "Press Release: New Site for Microbiology and DNA Analysis in Bremerhaven. Q-Bioanalytic Strengthens the Eurofins Laboratory Network". 2019-02-11
Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig. 2019-02-08
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
Uniqure N.V.. (2/8/19). "Press Release: Uniqure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-02-08
Sartorius AG. (2/8/19). "Press Release: Andrew Alliance and Sartorius Collaborate to Provide Software-connected Pipettes for Life Science Research". Göttingen & Geneva. 2019-02-08
Lunaphore Technologies S.A.. (2/7/19). "Press Release: Lunaphore Launches Its First Product LabSat". Lausanne. 2019-02-07
Evotec AG. (2/7/19). "Press Release: Evotec Mourns Loss of Company Co-founder Prof. Manfred Eigen". Hamburg. 2019-02-07
Evotec AG. (2/7/19). "Press Release: Evotec and Galapagos Enter into Collaboration in the Field of Fibrosis". Hamburg & Mechelen. 2019-02-07
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
OSE Immunotherapeutics S.A.. (2/7/19). "Press Release: OSE Immunotherapeutics and Servier Announce First Option within Global License Agreement Exercised for further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases". 2019-02-07
Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona. 2019-02-07
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. 2019-02-07
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases". South San Francisco, CA. 2019-02-07
Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results". South San Francisco, CA. 2019-02-07
Sygnature Discovery Ltd.. (2/7/19). "Press Release: Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership to Develop First in Class Therapies in Autoimmune Disease and Immuno-oncology". Oxford & Nottingham. 2019-02-07
Oxford Biomedica plc. (2/7/19). "Press Release: Oxford Biomedica Provides Update on Programmes Outlicensed to Sanofi". Oxford. 2019-02-07
Altona Diagnostics GmbH. (2/7/19). "Press Release: Altona Diagnostics Receives CE-IVD Mark for HCV RT-PCR Test". Hamburg. 2019-02-07
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
Roche. (2/6/19). "Press Release: Roche Joins the World Federation of Hemophilia Humanitarian Aid Program". Basel. 2019-02-06
Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. 2019-02-06
Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". 2019-02-06
Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. 2019-02-06
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2019-02-06
MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: Sanofi’s Board of Directors Notes the Resignation of Christian Mulliez and Co-opts Christophe Babule as Director". Paris. 2019-02-06
Inari. (2/6/19). "Press Release: Inari Broadens Research Footprint with Expansion to Belgium Life Sciences Hub". Cambridge, MA. 2019-02-06
Optimapharm d.d.. (2/6/19). "Press Release: Optimapharm Acquires Swiss Denothex and Becomes a Leading European Mid-size Clinical Research Organization". 2019-02-06
ProteoNic Biotechnology B.V.. (2/5/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company". Leiden. 2019-02-05
MorphoSys AG. (2/5/19). "Press Release: MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.". Planegg. 2019-02-05
Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. 2019-02-05
Sanofi S.A.. (2/5/19). "Press Release: Isatuximab Phase 3 Trial Meets Primary Endpoint of Prolonging Progression Free Survival in Patients with Relapsed/Refractory Multiple Myeloma". Paris. 2019-02-05
Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. 2019-02-05
next pagenext page 1 2 3 ... 62 63 64  next pagenext page



Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top